0.68
price down icon10.51%   -0.0799
after-market 시간 외 거래: .68
loading

Vaxart Inc 주식(VXRT)의 최신 뉴스

pulisher
May 14, 2026

Vaxart (VXRT) Institutional Ownership 2026 $VXRT - MarketBeat

May 14, 2026
pulisher
May 09, 2026

MSN Money - MSN

May 09, 2026
pulisher
May 09, 2026

Vaxart anticipates early 2027 primary efficacy readout while aiming for Q2 sentinel data release - MSN

May 09, 2026
pulisher
May 08, 2026

Vaxart (VXRT) Reports Progress in Clinical Programs and Financia - GuruFocus

May 08, 2026
pulisher
May 08, 2026

VXRT: Revenue surged and net income turned positive as clinical milestones and funding flexibility advanced - TradingView

May 08, 2026
pulisher
May 08, 2026

Earnings call transcript: Vaxart’s mixed Q1 2026 results, EPS beats forecast By Investing.com - Investing.com South Africa

May 08, 2026
pulisher
May 08, 2026

VXRT: Revenue doubled year-over-year, with clinical milestones and cash runway into Q2 2027 - TradingView

May 08, 2026
pulisher
May 08, 2026

[S-1] Vaxart, Inc. Files IPO Registration Statement - Stock Titan

May 08, 2026
pulisher
May 08, 2026

Earnings call transcript: Vaxart’s mixed Q1 2026 results, EPS beats forecast - Investing.com

May 08, 2026
pulisher
May 08, 2026

Vaxart Q1 2026 Earnings Call Transcript - MarketBeat

May 08, 2026
pulisher
May 07, 2026

Vaxart : Quarterly Report for Quarter Ending March 31, 2026 (Form 10-Q) - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

Vaxart targets Q2 data from 400-person oral COVID vaccine study - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results - The Manila Times

May 07, 2026
pulisher
May 07, 2026

Vaxart, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026
pulisher
May 07, 2026

Vaxart (OTCQX: VXRT) swings to Q1 2026 profit on BARDA and collaboration revenue - Stock Titan

May 07, 2026
pulisher
May 07, 2026

Vaxart (OTCQX: VXRT) swings to Q1 2026 profit as COVID trial advances - Stock Titan

May 07, 2026
pulisher
May 04, 2026

Vaxart (VXRT) files ATM supplement to raise up to $49.8M via Sales Agents - Stock Titan

May 04, 2026
pulisher
May 03, 2026

Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts - MSN

May 03, 2026
pulisher
May 01, 2026

Vaxart (VXRT) director James B. Breitmeyer files initial Form 3 with no trades - Stock Titan

May 01, 2026
pulisher
May 01, 2026

Vaxart (NASDAQ: VXRT) awards 78,800 RSUs and 157,400 options to director - Stock Titan

May 01, 2026
pulisher
May 01, 2026

Earnings Preview: Vaxart to Report Financial Results Post-market on May 07 - Moomoo

May 01, 2026
pulisher
May 01, 2026

Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET - The Manila Times

May 01, 2026
pulisher
May 01, 2026

Vaxart to report Q1 2026 results May 7 and host stockholder chat May 8 - Pluang

May 01, 2026
pulisher
May 01, 2026

[EFFECT] Vaxart, Inc. SEC Filing - Stock Titan

May 01, 2026
pulisher
Apr 30, 2026

Q3 2025 Vaxart Inc Earnings Call Transcript - GuruFocus

Apr 30, 2026
pulisher
Apr 30, 2026

VXRT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Vaxart (OTCQX: VXRT) outlines 2025 governance, pay and ownership - Stock Titan

Apr 30, 2026
pulisher
Apr 30, 2026

Akin, an Elite Global Law Firm - Akin

Apr 30, 2026
pulisher
Apr 29, 2026

Vaxart Investors Come Up Empty in Trial Against Insider Fund (3) - Bloomberg Law News

Apr 29, 2026
pulisher
Apr 28, 2026

BREAKING: Jury Clears Armistice Capital, Execs Of Securities Fraud - Law360

Apr 28, 2026
pulisher
Apr 28, 2026

Book value per share of Vaxart, Inc. – MUN:NB11 - TradingView

Apr 28, 2026
pulisher
Apr 28, 2026

Jury Clears Armistice Capital, Execs Of Securities Fraud - Law360

Apr 28, 2026
pulisher
Apr 27, 2026

Did Hedge Fund 'Greed' Hurt Vaxart Investors? Jury To Decide - Law360

Apr 27, 2026
pulisher
Apr 27, 2026

Vaxart announces $25M share purchase agreement - MSN

Apr 27, 2026
pulisher
Apr 26, 2026

The 3 penny stocks you swore you'd never buy (but you'll check anyway) - MSN

Apr 26, 2026
pulisher
Apr 24, 2026

Vaxart (OTCMKTS:VXRT) Stock Passes Above 50-Day Moving AverageTime to Sell? - MarketBeat

Apr 24, 2026
pulisher
Apr 24, 2026

Vaxart, Inc. Files Form 8-K for Common Stock (VXRT) on April 23, 2026 – Company Details and SEC Compliance - Minichart

Apr 24, 2026
pulisher
Apr 24, 2026

Vaxart adds James Breitmeyer to board of directors By Investing.com - Investing.com Australia

Apr 24, 2026
pulisher
Apr 23, 2026

Vaxart Adds Veteran Biotech Leader to Board - TipRanks

Apr 23, 2026
pulisher
Apr 23, 2026

Vaxart adds James Breitmeyer to board of directors - Investing.com

Apr 23, 2026
pulisher
Apr 23, 2026

Vaxart, Inc. Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors to Enhance Clinical Development and Regulatory Expertise - Quiver Quantitative

Apr 23, 2026
pulisher
Apr 23, 2026

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors - The Manila Times

Apr 23, 2026
pulisher
Apr 23, 2026

Vaxart, Inc. Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors - marketscreener.com

Apr 23, 2026
pulisher
Apr 23, 2026

Press Release: Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors - Moomoo

Apr 23, 2026
pulisher
Apr 22, 2026

Vaxart, Inc. Files Form 8-K with SEC – Company Information and Details for April 20, 2026 - Minichart

Apr 22, 2026
pulisher
Apr 21, 2026

Armistice Capital Head Calls COVID Stock Rise 'Fun,' 'Lucky' - Law360

Apr 21, 2026
pulisher
Apr 21, 2026

Vaxart amends lease to add Utah Avenue space, ends Harbor Way lease in May - Investing.com Canada

Apr 21, 2026
pulisher
Apr 21, 2026

Vaxart amends lease to add Utah Avenue space, ends Harbor Way lease in May By Investing.com - Investing.com South Africa

Apr 21, 2026
$29.29
price down icon 0.71%
$89.55
price down icon 2.65%
$52.85
price down icon 1.03%
$109.14
price down icon 5.60%
ONC ONC
$293.27
price down icon 3.73%
$145.66
price down icon 2.55%
자본화:     |  볼륨(24시간):